Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas

European Journal of Endocrinology

Volumn 147, Issue 3, 2002, Pages 349-355

  Patócs, Attila ^a   Tóth, Miklós ^a   Barta, Csaba ^a   Sasvári Székely, Mária ^a   Varga, Ibolya ^a   Szücs, Nikolette ^a   Jakab, Csilla ^a   Gláz, Edit ^a   Rácz, Károly ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARAGINE; CORTICOTROPIN; DNA; GLYCINE; HYDROXYPROGESTERONE; ISOLEUCINE; LEUCINE; RNA; STEROID 21 MONOOXYGENASE; TRYPTOPHAN; VALINE;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; ADRENALECTOMY; ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE CONVERSION; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GERM LINE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; INTRON; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RNA SPLICING; SOMATIC MUTATION; STEROID 21 MONOOXYGENASE DEFICIENCY;

EID: 0036737764     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470349     Document Type: Article

References (45)

1. Kloos RT, Gross MD, Francis IR, Korobkin M & Shapiro B. Incidentally dicovered adrenal masses. Endocrine Reviews 1995 16 460-483.
2. Ross NS & Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. New England Journal of Medicine 1990 323 1401-1405.
3. Copeland PM. The incidentally discovered adrenal mass. Annals of Internal Medicine 1993 98 940-945.
4. Glazer HS, Weyman PJ, Sagel SS, Levitt RG & McClennan BL. Non-functioning adrenal masses: incidental discovery on computed tomography. American Journal of Roentgenology 1982 139 81-85.
5. Peppercorn PD, Grossman AB & Rezneck RH. Imaging of incidentally discovered adrenal masses. Clinical Endocrinology 1966 48 379-388.
6. Griffing G. Editorial: A-I-D-S: The new endocrine epidemic. Journal of Clinical Endocrinology and Metabolism 1994 79 1530-1531.
7. Hedeland H, Östberg G & Hökfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Medica Scandinavica 1968 184 211-214.
8. Russel R, Masi A & Richter E. Adrenal cortical adenomas and hypertension. A clinical pathologic analysis of 690 cases with matched controls and a review of the literature. Medicine 1972 51 211-215.
9. Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J, Migdalska B, Jeske W, Makowska A et al. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clinical Endocrinology 1997 46 29-37.
10. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM & Ali A. A survey on adrenal incidentaloma in Italy. Journal of Clinical Endocrinology and Metabolism 2000 85 637-644.
11. Herrera MF, Grant CS, van Heerden JA, Sheedy PF & Istrup D.M. Incidentally discovered adrenal tumors: an institutional perspective. Surgery 1991 110 1014-1021.
12. Gláz E, Rćz K, Varga I, Kiss R, Töth M & Fütö L. Mineralocorticoid production of adrenal cortical adenomas. Journal of Steroid Biochemistry 1993 45 57-84.
13. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B & Winkelman W. Preclinical Cushing's syndrome in adrenal incidentalomas. Comparison with adrenal Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1992 75 826-832.
14. Hensen J, Buhl M, Bahr V & Oelker W. Endocrine activity of the silent adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Klinische Wochenschrift 1990 68 608-614.
15. Osella G, Terzolo M, Borretta G, Magra G & Piovesan AA. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas). Journal of Clinical Endocrinology and Metabolism 1994 79 1532-1539.
16. Tóth M, Rácz K, Adleff V, Varga I, Fütö L, Jakab C et al. Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after adrenalectomy. Journal of Endocrinological Investigation 2000 23 287-294.
17. Bernini GP, Brogi G, Vivaldi MS, Argenio GF, Sgro M, Moretti A et al. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas. Journal of Endocrinological Investigation 1996 19 745-752.
18. Del Monte P, Bernasconi D, Bertolazzi L, Meozzi M, Badaracco B & Torne R. Increased 17α-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause or effect? Clinical Endocrinology 1995 42 273-277.
19. Reincke M, Peter M, Sippel WG & Allolio B. Impairment of 11α-hydroxylase but not 21-hydroxylase in adrenal incidentalomas. European Journal of Endocrinology 1997 136 196-200.
20. Seppel T & Schlghecke R. Augmented 17-alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours (incidentalomas). Clinical Endocrinology 1994 41 445-451.
21. Terzolo M, Osella G, Ali A, Borretta G, Magro G-P, Termine A et al. Different patterns of steroid secretion in patients with adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism 1996 81 740-744.
22. Turton DB, O'Brian JT & Shakin KMM. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone. Journal of Endocrinological Investigation 1992 15 789-796.
23. Jaresch S, Kornely E, Kley H-K & Schlaghecke R. Adrenal incidentalomas and patients with homozygous or heterozygous congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1992 74 685-689.
24. Beuschlein F, Schulze E, Mora P, Gensheimer H-P, Maser-Gluth C, Allolio B et al. Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 2585-2588.
25. Kjellman M, Holst M, Backdahl M, Larsson C, Farnebo L-O & Wedell A. No overrepresentation of congenital adrenal hyperplasia in patients with adrenocortical tumours. Clinical Endocrinology 1999 50 343-346.
26. Vecsei P. Glucocorticoids: cortisol, cortisone, corticosterone, compound S and their metabolites. In Methods of Hormone Radio-immunoassay pp 767-796. Eds BM Jaffe & HR Behrman. New York: Academic Press, 1979.
27. Vecsei P, Onyechi J, Hornung J, Dietz R, Mast G & Hobler H. Use of corticosteroid antibodies for the study of corticosteroid biosynthesis in vitro. Journal of Steroid Biochemistry 1975 6 383-387.
28. Wedell A, Thilén A, Stengler B, Ritzén E & Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implication for genetic diagnosis and association with disease manifestation. Journal of Clinical Endocrinology and Metabolism 1994 78 1145-1152.
29. Wedell A & Luthman H. Steroid 21-hydroxylase deficiency: two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations. Human Molecular Genetics 1993 2 499-504.
30. White PC & New MI. Genetic basis of endocrine disease 2: congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 1992 74 6-11.
31. Abo K, Sumino K, Nishio H, Hozumi T, Ishida Y, Fujieda T et al. 21-Hydroxylase deficiency presenting as massive bilateral adrenal masses in the seventh decade. Endocrine Journal 1999 46 817-823.
32. Mokshagundam S & Surks MI. Congenital adrenal hyperplasia diagnosed in a man during workup for bilateral adrenal masses. Archives of Internal Medicine 1993 153 1389-1391.
33. Ravichandran R, Lafferty F, McGinnis MJ & Taylor HC. Congenital adrenal hyperplasia presenting as massive adrenal incidentalomas in the sixth decade of life: report of two patients with 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 1996 81 1776-1779.
34. Miller WL. Genetics, diagnosis, and management of 21-hydroxylase deficiency. Journal of Clinical Endocrinology and Metabolism 1994 78 241-246.
35. Rumsby G, Avey CJ, Conway GS & Honour JW. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms. Clinical Endocrinology 1998 48 707-711.
36. Witchel SF & Lee PA. Identification of heterozygotic carriers of 21-hydroxylase deficiency - sensitivity of ACTH stimulation test. American Journal of Medical Genetics 1998 76 337-342.
37. New MI & Speiser PW. Genetics of adrenal steroid 21-hydroxylase deficiency. Endocrine Reviews 1986 7 331-349.
38. Witchel SF, Lee PA, Suda-Hartman M & Hoffmann EP. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochemical and Molecular Medicine 1997 62 151-158.
39. Dumic M, Brkljacic L & Speiser PW. An update on the frequency of nonclassic deficiency of adrenal 21-hydroxylase in the Yugoslav population. Acta Endocrinologica 1990 122 703-710.
40. Sherman SL, Aston CE, Morton NE, Speiser PW & New MI. A segregation and linkage study of classical and nonclassical 21-hydroxylase deficiency. American Journal of Human Genetics 1988 42 830-838.
41. Speiser PW, New MI, Tannin GM, Pickering D, Yang SY & White PC. Genotype of Yupik Eskimos with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human Genetics 1992 88 647-648.
42. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A & New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. American Journal of Human Genetics 1985 37 650-667.
43. Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW et al. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1999 84 960-966.
44. Ferenczi A, Garami M, Kiss E, Pék M, Sasvári-Székely M, Barta C et al. Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism 1999 84 2369-2372.
45. Rácz K, Pinet F, Marton T, Szende B, Gláz E & Corvol P. Expression of steroidogenic enzyme messenger ribonucleic acids and corticosteroid production in aldosterone-producing and nonfunctioning adrenal adenomas. Journal of Clinical Endocrinology and Metabolism 1993